
Cardiologist

No OPD information available
Heart Attack
Acute Coronary Syndrome
Coronary Heart Disease
Endocarditis
Percutaneous Coronary Intervention (PCI)
Rohan Rajaratnam is a male healthcare provider who specializes in treating heart-related conditions like heart attacks, acute coronary syndrome, coronary heart disease, endocarditis, and performing procedures like percutaneous coronary intervention (PCI).
Rohan Rajaratnam helps patients with heart problems using special skills and treatments. He is good at communicating with patients, making them feel comfortable and earning their trust. Patients trust him because he listens to their concerns and explains things clearly.
Rohan Rajaratnam stays updated with the latest medical knowledge and research to provide the best care for his patients. He reads medical journals, attends conferences, and collaborates with other experts in the field to learn new things.
Rohan Rajaratnam works well with colleagues and other medical professionals. He values teamwork and respects others' opinions, which helps him provide comprehensive care to his patients. His colleagues appreciate his dedication and expertise.
Rohan Rajaratnam's work has positively impacted many patients' lives. His treatments have helped patients recover from heart conditions and lead healthier lives. His research and publications have also contributed to advancing medical knowledge in the field of cardiology.
One of Rohan Rajaratnam's notable publications is "Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience" in the journal Heart, Lung & Circulation. He has also been involved in clinical trials, such as the study on Anti-chlamydophila Antibiotic Combination (ACAC) therapy for patients with coronary heart disease.
In summary, Rohan Rajaratnam is a dedicated healthcare provider who specializes in treating heart conditions, communicates effectively with patients, stays updated with the latest medical knowledge, collaborates well with colleagues, and has made a positive impact on patients' lives through his work and research.
Enrollment Status: Terminated
Published: August 02, 2021
Intervention Type: Drug
Study Drug:
Study Phase: Phase 2
